Value Strategy & Access Director – Rare Disease & Oncology

Amgen SA; Thousand Oaks (CA); On-site; USD 180,000 - 240,000; Full time

Job summary

Amgen seeks a Director, Value Strategy & Marketing for Rare Disease & Oncology in Thousand Oaks. You will align payer insights, evidence strategy, value communication, and customer engagement to secure sustainable coverage and patient access across inline, launch, and pipeline assets.

The role requires senior leadership in cross-functional teams and a proven ability to translate clinical and economic evidence into compelling payer value stories.

Qualifications

• Doctorate degree with 4+ years of commercial experience or equivalent
• Master’s degree with 7+ years of commercial experience
• Bachelor’s degree with 9+ years of commercial experience

Responsibilities

• Lead portfolio value strategy across Rare Disease and Oncology.
• Translate brand objectives and payer dynamics into priorities and strategies.
• Define differentiated payer value propositions with evidence translation.
• Guide payer-relevant evidence strategy with HEOR, CfOR, Medical, Brand, and Insights.
• Ensure payer considerations are integrated into launch, expansion and lifecycle planning.
• Partner with Market Access and MVPH leadership on engagement priorities.
• Coordinate with Coverage & Pricing to align value strategy with contracting.
• Oversee development of payer value resources and tools.
• Lead and coach two Senior Managers with clear ownership and rhythms.
• Champion AI-enabled ways of working to accelerate insight synthesis.
• Build AI capability across the team and ensure compliant use.
• Manage portfolio budgets, agency relationships, and investments.

Skills

People leadership

Executive communication

Strategic thinking

Cross-functional collaboration

AI / generative AI awareness

Education

Doctorate degree

Master’s degree

Bachelor’s degree

Job description

Amgen seeks a Director, Value Strategy & Marketing for Rare Disease & Oncology in Thousand Oaks. You will align payer insights, evidence strategy, value communication, and customer engagement to secure sustainable coverage and patient access across inline, launch, and pipeline assets.

The role requires senior leadership in cross-functional teams and a proven ability to translate clinical and economic evidence into compelling payer value stories.